癌症病患接受造血幹細胞移植的症狀困擾與生活品質

Symptom Distress and Quality of Life in Cancer Patients Following Hematopoietic Stem Cell Transplantation

10.6142/VGHN.201806_35(2).0007

梁天麗(Tien-Li Liang)；劉介宇(Chieh-Yu Liu)；陳夏蓮(Shiah-Lian Chen)；林惠如(Hung-Ru Lin)

造血幹細胞移植 ； 症狀困擾 ； 生活品質 ； haematopoietic stem cell transplantation ； symptom distress ； quality of life

榮總護理

35卷2期（2018 / 06 / 01）

173 - 184

繁體中文

本研究主要探討癌症病患接受造血幹細胞移植症狀困擾與生活品質情形，採橫斷相關性研究設計，於中部某醫學中心血液腫瘤科以方便取樣進行收案，收案條件為(一)年滿二十歲；(二)診斷為實體與血液腫瘤病患、接受週邊造血幹細胞移植；(三)無認知功能缺損、具口語表達能力；(四)同意參與研究者，共收案100人。問卷包括「基本屬性」、「症狀困擾量表中文修訂版」、「中文版癌症治療功能性評估-骨髓移植第四版」。資料統計採個人電腦SPSS18.0統計軟體進行分析統計。結果為(一)病患平均移植為32.67個月，症狀困擾平均得分40.77分，為低等困擾程度；(二)整體生活品質平均為110.05，為中高的程度；(三)症狀困擾與生活品質有顯著負相關(r=-.652, p＜.05)；其中急慢性移植物抗宿主反應、年齡大於50歲、移植前有職業者可顯著預測症狀困擾；移植後有職業者、急性移植物抗宿主反應與復發可顯著預測生活品質。期望透過研究結果加強血液腫瘤專業醫護人員症狀護理能力，針對年紀大於50歲之移植病患特別關注其症狀困擾的影響，加強護理人員對急慢性移植物抗宿主反應的專業知識與衛教能力，並諮詢對於病患返家後工作的銜接與因應，以期提升移植後的生活品質。

Purpose: To explore symptom distress and quality of life (QOL) in cancer patients following hematopoietic stem cell transplantation (HSCT) in Taiwan. Methods: A cross-sectional correlational study was conducted by recruiting 100 patients who underwent transplantation at a bone marrow transplantation unit. The sample was selected using convenience sampling. The inclusion criteria were as follows: (1) aged 20 years or older, (2) had undergone hematopoietic stem cell transplant, (3) had no obvious cognitive impairments, and (4) had consented to participate. A questionnaire was employed to collect participants' demographic data, and it incorporated the Symptom Distress Scale-Chinese Modified Form (SDS-CMF) and the Traditional Chinese version of the Functional Assessment of Cancer Therapy-Bone Marrow Transplantation Subscale (FACT-BMT). Statistical analyses were conducted using SPSS version 18.0. Results: The mean time post transplantation of the participants was 32.67 months. The mean SDS-CMF score for all patients was 40.77, which indicated low symptom distress. In addition, the mean overall FACT-BMT score for all patients was 110.05, which indicated that the patients had favorable QOL. Symptom distress and QOL had a significant negative correlation, with lower symptom distress resulting in higher QOL. Multiple regression analysis revealed the following predictors associated with QOL: acute graft-versus-host disease, patient age ＞ 50 years, and employment prior to undergoing HSCT. Implications for practice: Medical teams including physicians, clinical psychologists, social workers, and care coordination nurses must work with patients for symptom management of graft-versus-host disease. In addition, supporting patients with career planning may improve their QOL. This research is especially useful for consideration among older populations.

1. Baker, F.,Zabora, J.,Polland, A.,Wingard, J.(1999).Reintegration after bone marrow transplantation.Cancer Practice,7(4),190-197.
2. Bevans, M. F.,Marden, S.,Leidy, N. K.(2006).Health related quality of life in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.Bone Marrow Transplantation,38(2),101-109.
3. Bevans, M. F.,Mitchell, S. A.,Barrett, J.A.,Bishop, M. R.,Childs, R.,Fowler, D.,Yang, L.(2014).Symptom distress predicts long-term health and well-being in allogeneic stem cell transplantation survivors.Biol Blood Marrow Transplant,20(3),387-395.
4. Braamse, A, M. J.,van Meijel, B.,Visser, O.,Huijgens, P. C.,Beekman, A. T. F.,Dekker, J.(2014).Distress, problems and supportive care needs of patients treated with auto- or allo-SCT.Bone Marrow Transplantation,49(2),292-298.
5. Campagnaro, E.,Saliba, R.,Giralt, S.,Roden, L.,Mendoza, F.,Aleman, A.,Anderson, K. O.(2008).Symptom burden after autologous stem cell transplantation for multiple myeloma.Cancer,112(7),1617-1624.
6. Cohen, M. Z.,Rozmus, C. L. Mendoza, T. R.,Padhye, N. S.,Neumann, J.,Gning, I.,Cleeland, C. S.(2012).Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation.Journal of Pain and Symptom Management,44(2),168-180.
7. Conner-Spady, B.L.,Cumming, C.,Nabholtz, J. M.,Jacobs, P.,Stewart, D.(2005).A longitudinal prospective study of health-related quality of life in breast cancer patients following highdose chemotherapy with autologous blood stem cell transplantation.Bone Marrow Transplantation,3(6),251-259.
8. Epstein, J.B.,Phillips, N.,Parry, J.,Epstein, M.S.,Nevill, T.,Stevenson-Moore, P.(2002).Quality of life, taste, olfactory andoral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation.Bone Marrow Transplantation,30(11),785-792.
9. Ferrans, C. E.,Powers, M. J.(1992).Psychometric assessment of the quality of life index.Research in Nursing & Health,15(1),29-38.
10. Ferrara, J. L.,Levine, J. C.,Reddy, P.,Holler, E.(2009).Graft-versus-host disease.Lancet,373(9674),150-152.
11. Frödin, U.,Lotfi, K.,Fomichov, V.,Juliusson, G.,Börjeson, S.(2015).Frequent and longterm follow-up of health-related quality of life following allogeneic haematopoietic stem cell transplantation.European Journal of Cancer Care,24(6),898-910.
12. Fu, M. R.,LeMone, P.,McDaniel, R. W.(2004).An integrated approach to an analysis of symptom management in patients with cancer.Oncology Nursing Forum,31(1),65-70.
13. Gregurek, R.,Brajkovic, L.,Kalenic, B.,Bras, M.,Persic-Brida, M.(2009).Five years study on impact of anxiety on quality of life in patients treated with bone marrow transplantation.Psychiatr Danub,21(1),49-55.
14. Grulke, N.,Albani, C.,Bailer, H.(2012).Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire QLQ-C30.Bone Marrow Transplantation,47(4),473-482.
15. Hensel, M.,Egerer, G.,Schneeweiss, A.,Goldschmidt, H.,Ho, A. D.(2002).Quality of life and rehabilitation in social and professional life after autologous stem cell transplantation.Annals of Oncology,13(2),209-217.
16. Kav, S.,Aslan, O.,Tekin, F.,Yesil, H.,Mera, C.,Ozturk, U.(2009).Quality of life and difficulties of patients encountered after autologous stem cell transplantation.Journal of Balkan Union of Oncology,14(4),673-680.
17. King, C. R.,Hinds, P. S.(2011).Quality Of Life : From Nursing And Patient Perspectives: Theory, Research, Practice.Jones & Bartlett Learning.
18. Lau, A. K. L.,Chang, C. H.,Tai, J. W. M.,Eremenco, S.,Liang, R.,Lie, A. K. W.,Lau, C. M.(2002).Translation and validation of the Functional Assessment of Cancer Therapy–Bone Marrow Transplant (FACT-BMT) Version 4 quality of life instrument into traditional Chinese.Bone Marrow Transplantation,29(1),41-49.
19. Lee, S. J.,Fairclough, D.,Parsons, S.K.(2001).Recovery after stem-cell transplantation for hematologic diseases.Journal of Clinical Oncology,19(1),242-252.
20. Lee, S. J.,Kim, H. T.,Ho, V. T.,Culter, C.,Alyea, E. P.,Soiffer, R. J.,Antin, J. H.(2006).Quality of life associated with acute and chronic graft-versus-host disease.Bone Marrow Transplanationt,38(4),305-310.
21. McCorkle, R.,& Young, K.(1978).Development of a symptom distress scale.Cancer Nursing,1(5),373-378.
22. Molassiotis, A.,Boughton, B. J.,Burgoyne,T.,van den Akker, O. B.(1995).Comparison of the overall quality of life in 50 longterm survivors of autologous and allogeneic bone marrow transplantation.Journal of Advanced Nursing,22(3),509-516.
23. Ovayolu, O.,Ovayolu, N.,Kaplan, E.,Pehlivan, M.,Karadag, G.(2013).Symptoms and quality of life: Before and after stem cell transplantation in cancer.Pakistan Journal of Medical Sciences,29(3),803-808.
24. Pallua, S.,Giesinger, J.,Oberguggenberger, A.,Kemmler, G.,Nachbaur, D.,Clausen, J.,Holzner, B.(2010).Impact of GVHD on quality of life in long-term survivors of haematopoietic transplantation.Bone Marrow Transplantation,45(10),1534-1539.
25. Passweg, J. R.,Baldomero, H.,Gratwohl, A.,Bregni, M.,Cesaro, S.,Dreger, P.,Madrigal A.(2012).For the European group for blood and marrow transplantation (EBMT). The EBMT activity survey: 1990-2010.Bone Marrow Transplantation,47(7),906-923.
26. Russell, C.,Harcourt, D.,Henderson, L.,Marks, D.(2010).Patients' experiences of appearance changes following allogeneic bone marrow transplantation.Cancer Nursing,34(4),315-321.
27. Saleh, U.S.,Brockopp, D.Y.(2001).Quality of life one year following bone marrow transplantation: Psychometric evaluation of the quality of life in bone marrow transplant survivors tool.Oncology Nursing Forum,28(9),1457-1464.
28. Sherman, R. S.,Cooke, E.,Grant, M.(2005).Dialogue among survivors of hematopoietic cell transplantation support-group themes.Journal of Psychosocial Oncology,23(1),1-24.
29. 姚開屏(2002)。健康相關生活品質概念與測量原理之簡介。台灣醫學，6(2)，183-192。
30. 莊紫雲、劉淑珍、李宜恬、謝麗鳳(2015)。造血幹細胞移植後病人之生活品質及症狀探討。榮總護理，32(2)，208-218。
31. 鄒綉珍(2011)。碩士論文(碩士論文)。台北，國立台灣大學研究所。
32. 賴裕和(1998)。門診接受化學治療病患之症狀困擾及居家護理需求探討。護理研究，6(4)，279-288。

1. 陳榆心,陳雅惠(2022)。一位骨髓增生不良症候群病人接受異體移植之照護經驗。榮總護理，39(2)，146-152。
2. 羅惠敏,陳文香(2022)。血液腫瘤住院患者的心理調適與復原力之縱貫性研究。腫瘤護理雜誌，22(2)，5-20。
3. 鄭雅君,葉惠玲,李珍妮,池雅頻(2023)。印尼籍白血病患者來臺接受異體造血幹細胞移植之護理經驗。志為護理-慈濟護理雜誌，22(5)，103-112。